| NeuroNova in Brief |
|
We believe therapeutic neurogenesis and neuroprotection can revolutionize the treatment of several currently incurable neurodegenerative diseases, including Parkinson’s disease, Alzheimer’s disease, amyotrophic lateral sclerosis (ALS) and Huntington's disease. |
|
| © NeuroNova AB, Sweden, Tel: +46 (0)8 786 0900, Email: This e-mail address is being protected from spam bots, you need JavaScript enabled to view it | |
| Sitemap Site policy |
